WuXi Ramps Up Genomics Offering In China Via Foundation Medicine Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
WuXi PharmaTech signs a deal with Foundation Medicine to offer a cancer genomics decoding service to customers in China, part of plans announced earlier this year to expand services to innovators.